Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Quest Diagnostics
(NY:
DGX
)
151.68
+0.77 (+0.51%)
Streaming Delayed Price
Updated: 9:48 AM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Quest Diagnostics
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Down 40% in 2022, Can Exact Sciences Recover in 2023?
January 23, 2023
Investors are attracted to its leading position in the market for early cancer detection, but the persistent losses its been reporting are enough to make anyone nervous.
Via
The Motley Fool
Analyst Ratings for Quest Diagnostics
January 06, 2023
Via
Benzinga
These 2 Defensive Plays Are Highlights Of CNBC's 'Final Trades'
December 23, 2022
On CNBC’s "Halftime Report: Final Trades," Shannon Saccocia of Boston Private said Quest Diagnostics Inc (NYSE: DGX) is expected to grow 4% to 5%
Via
Benzinga
Where Quest Diagnostics Stands With Analysts
December 14, 2022
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
December 01, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Golden Cross Appears Before Quest Diagnostics Investors
November 28, 2022
Via
Benzinga
Where Quest Diagnostics Stands With Analysts
November 17, 2022
Via
Benzinga
Why Quest Diagnostics Stock Jumped Today
October 20, 2022
Growth in the lab testing titan's core business is accelerating.
Via
The Motley Fool
Quest Diagnostics Q3 Earnings Surpass Expectations, Raises Annual Guidance
October 20, 2022
Via
Benzinga
Quest Diagnostics Lifts Annual Guidance On Higher COVID-19 Test Revenue Anticipation
July 21, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2022
November 17, 2022
Upgrades
Via
Benzinga
Quest Diagnostics To Plunge 16%? Here Are 5 Other Price Target Changes For Thursday
November 17, 2022
Via
Benzinga
DermTech and Sonora Quest Laboratories Expand Access to Innovative Melanoma Detection Test
November 15, 2022
From
DermTech, Inc.
Via
Business Wire
Here’s Why Quest Diagnostics Stock Should Be in Your Portfolio
October 31, 2022
Medical diagnostic lab company Quest Diagnostic (NYSE: DGX) stock has been trading within a boxed range from $126 to $146 for the majority of 2022.
Via
MarketBeat
Exposures
COVID-19
Quest Diagnostics: Q3 Earnings Insights
October 20, 2022
Quest Diagnostics (NYSE:DGX) reported its Q3 earnings results on Thursday, October 20, 2022 at 06:45 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Earnings Scheduled For October 20, 2022
October 20, 2022
Companies Reporting Before The Bell • ABB (NYSE:ABB) is estimated to report quarterly earnings at $0.38 per share on revenue of $7.35 billion.
Via
Benzinga
A Preview Of Quest Diagnostics's Earnings
October 19, 2022
Quest Diagnostics (NYSE:DGX) is set to give its latest quarterly earnings report on Thursday, 2022-10-20. Here's what investors need to know before the announcement. Analysts estimate that Quest...
Via
Benzinga
Eli Lilly, EQT, Cash Cows ETF, Northrop Grumman And This Diagnostics Company Feature On CNBC's Final Trade
October 03, 2022
On CNBC’s “Halftime Report Final Trades,” Bryn Talkington of Requisite Capital Management said Pacer US Cash Cows 100 ETF (BATS: COWZ) is “a factor-b
Via
Benzinga
What Fast Food And Entertainment Giants Did Traders Pick For CNBC's Fast Money Call Of The Day
September 30, 2022
CNBC’s "Fast Money Halftime Report" delivers market-moving news to investors. The commentary delivered by hosts of the show often moves the stocks mentioned. The information is collected and refined...
Via
Benzinga
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests
September 27, 2022
Via
Benzinga
COVID-19 Complacency Pushes Identification Of New Variants To Back Seat, WHO Warns
September 23, 2022
The World Health Organization (WHO) warned that it struggles to identify and
Via
Benzinga
Achievers and Quest Diagnostics Win Gold in the 2022 Brandon Hall Group Excellence Technology Awards
September 14, 2022
From
Achievers
Via
Business Wire
Quest Becomes Exclusive Validator For Results From The Hound Cannabis Breathalyzer
September 14, 2022
Hound Labs, creator of the Hound Cannabis Breathalyzer, entered into an agreement with Quest Diagnostics (NYSE: DGX), a provider of diagnostic information services.
Via
Benzinga
No More Free COVID-19 At-Home Tests, Federal Government Says
August 29, 2022
CNBC reported that the federal government is set to suspend its offer of free at-home COVID-19 tests by Friday, September 2, without congressional au
Via
Benzinga
3 Top Monkeypox Stocks to Buy Right Now
August 24, 2022
With cases of a frightening disease spreading to all 50 states, it’s now time to consider the top monkeypox stocks to buy right now.
Via
InvestorPlace
3 Monkeypox Stocks to Buy as Biden Declares Public Health Emergency
August 05, 2022
Monkeypox stocks are about to rise now that the White House has declared the virus a public health emergency. Here are the stocks to watch.
Via
InvestorPlace
Drug Testing At Work Is A Thing Of The Past, Study Finds
July 30, 2022
According to a study conducted by Quest Diagnostics Inc (NYSE: DGX), drug use among American employees, as measured by the percentage of employees who tested positive in urine drug tests, hit a
Via
Benzinga
4 Analysts Have This to Say About Quest Diagnostics
July 22, 2022
Analysts have provided the following ratings for Quest Diagnostics (NYSE:DGX) within the last quarter:
Via
Benzinga
Quest Diagnostics: Q2 Earnings Insights
July 21, 2022
Quest Diagnostics (NYSE:DGX) reported its Q2 earnings results on Thursday, July 21, 2022 at 06:45 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Earnings Scheduled For July 21, 2022
July 21, 2022
Companies Reporting Before The Bell • SAP (NYSE:SAP) is projected to report quarterly earnings at $1.15 per share on revenue of $7.56 billion.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.